When medications and conservative treatments fail, nasal polyp surgery becomes a vital option for relief. This minimally ...

A decision to proceed with nasal polyp surgery was recorded in just 0.5% of tezepelumab-treated patients compared to 22.1% in the placebo group (hazard ratio, 0.02). Systemic glucocorticoid use ...

In this randomized controlled trial, among patients with severe, uncontrolled chronic rhinosinusitis with nasal polyps, tezepelumab more effectively reduced nasal polyp size and sinonasal symptoms ...

A new CT-scan-based risk score facilitates the identification of patients at risk of revision endoscopic sinus surgery due to ...

When sinusitis does not respond to treatment, your doctor may recommend surgery to remove a polyp or nasal tissue.

Among patients with previous sinus surgery for chronic rhinosinusitis with nasal polyps, the number of past surgeries did not ...

The following is a summary of "Real-world comparison of T2-biologics effectiveness in severe allergic asthma with nasal ...

The need for systemic corticosteroids fell by 88%, and the need for surgery fell by 98%. Nasal polyp and congestion scores fell, along with loss of smell and total symptom scores. SAN DIEGO ...

significantly reducing nasal polyp size, nasal congestion severity, and the need for systemic corticosteroids and/or surgery. Rapid take-up of Dupixent in atopic dermatitis and asthma caused sales ...

Results from a drug trial showed AstraZeneca and Amgen's new drug Tezspire significantly reduced nasal polyp severity, the need for surgery and anti-inflammatory steroid use in patients with ...

In the polypoid form of the disease, mucosal protrusions, or polyps, block the ... of a high risk of revision surgery include non-detectable anatomy of the nasal turbinates, which is often ...